Nationwide Drug Shortage Could Cause Disruptions for Cancer Patients in Active Treatment
Chemotherapy drugs used to treat cancer are increasingly in short supply and have returned to the list of top-five drug classes affected by shortage.
National Press Releases
Survey Finds Majority of Cancer Patients and Survivors Would Be Less Likely to Get Recommended Screenings if Costs Were Added
A majority (58%) of cancer patients and survivors say they would be less likely to remain current with their recommended preventive care if it came with a cost, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN). Over half (53%) of those surveyed quantified the cost that would present such a barrier at less than $200, with more than a quarter (28%) marking their threshold at $100.
Declines in Cigarette Use by Adults Show Impact of Evidence-Based Tobacco Control Policies
Cigarette smoking declined from 12.5% in 2020 to 11.5% in 2021, but one in five, or 46 million, U.S. adults continues to use tobacco products in 2021 according to new data released today by the Centers for Disease Control and Prevention (CDC).
Patient Groups File Amicus Brief in Support of DOJ’s Motion for Stay to U.S. Court of Appeals for the Fifth Circuit
Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.
Patient Groups File Amicus Brief in Support of DOJ’s Motion for Stay to U.S. Court of Appeals for the Fifth Circuit
Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.
House Advances Problematic Public Health Provisions as Part of Debt Limit Proposal Bill
Today, the U.S. House of Representatives, in a 217-215 vote, passed the Limit, Save, Grow Act, advancing provisions that would greatly restrict access to affordable care and risk progress in the fight against cancer.
Lives On The Line As FDA Continues to Delay Finalizing Rules on Menthol in Cigarettes and Flavors in Cigars
Last year, the U.S. Food and Drug Administration (FDA) released its proposed rules to eliminate menthol cigarettes and eliminate all flavors in cigars. Now, nearly one year later, the rules are still not final. This inaction has allowed Big Tobacco to continue targeting these products to the Black community, who consistently reports the highest prevalence of menthol cigarette use.
ACS CAN Joins More Than 30 Patient and Provider Groups Applauding Supreme Court Ruling, Urging Courts to Preserve FDA’s Authority
ACS CAN joined 32 patient and provider groups 33 organizations applauding the Supreme Court’s decision to pause new restrictions that would have limited access to the FDA-approved drug mifepristone while litigation about the drug works its way through the courts.
Letter: Cancer Advocates Urge House Leadership to Refrain from Tying Debt Limit Proposal to Problematic Public Health Provisions
Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Speaker Kevin McCarthy and House Democratic Leader Hakeem Jeffries detailing concerns on provisions in the Limit, Save and Grow Act that would restrict access to affordable health care and risk progress in cancer research.
American Cancer Society and ACS CAN Applaud Reports of Newly Named National Institutes of Health Director
According to multiple news reports, President Biden has nominated Monica M. Bertagnolli, MD, to serve as the Director of the National Institutes of Health (NIH).